Anti-H5N1 avian influenza monoclonal antibody
抗H5N1禽流感鼠单抗
Report date: 2022/01/14 13:23:58
Base Information
Drug NameAnti-H5N1 avian influenza monoclonal antibody
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesXiamen Innovax Biotech Co LtdXiamen University
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesXiamen Innovax Biotech Co LtdXiamen University
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A